Sort
261,768 grants matching “gene therapy”
Lysosomal NADPH metabolism regulates proteostasis, aging and tauopathy
$1,591,453Weiwei Dang · Baylor College Of Medicine · RF1 · FY2021 · AG
ADP-ribosylation Cycles
$1,591,105Joel Moss · National Heart, Lung, And Blood Institute · ZIA · FY2024 · HL
Molecular Targets for Drug and Radiation Sensitivity
$1,591,052Stephen M Hahn · University Of Pennsylvania · P01 · FY2006 · CA
Mental Retardation &Developmental Disabilities Research
$1,590,796Children'S Hospital Boston · P30 · FY2003 · HD
Telomeres Diseases
$1,590,725Neal S Young · National Heart, Lung, And Blood Institute · ZIA · FY2011 · HL
Multiscale Analysis of Immune Responses
$1,590,437Ronald Germain · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
A Program for Innovative PET Radioligand Development and Application - A Translational Toolbox for Treatments for Mental Health
$1,590,284Richard E Carson · Yale University · U01 · FY2024 · MH
A Program for Innovative PET Radioligand Development and Application - A Translational Toolbox for Treatments for Mental Health
$1,590,284Richard E Carson · Yale University · U01 · FY2025 · MH
A Program for Innovative PET Radioligand Development and Application - A Translational Toolbox for Treatments for Mental Health
$1,590,284Richard E Carson · Yale University · U01 · FY2023 · MH
Clonal analysis of in vivo hematopoiesis
$1,590,278Cynthia E Dunbar · National Heart, Lung, And Blood Institute · ZIA · FY2017 · HL
NHGRI/DIR Technology Transfer Program
$1,590,131Daniel Kastner · National Human Genome Research Institute · ZIK · FY2011 · HG
A Phase I Clinical Trial Testing Feasibility of Hematopoietic Stem Cell Gene Therapy Using Platelet Factor VIII to Safely Improve Hemostasis for Severe Hemophilia A with Inhibitory Antibodies
$1,589,707David Allen Wilcox · Medical College Of Wisconsin · R01 · FY2022 · HL
Center for the Neurobiology of Addiction Treatment
$1,589,690Michael A Nader · Wake Forest University Health Sciences · P50 · FY2019 · DA
SPORE in Ovarian Cancer
$1,589,106Ie-Ming Shih · Johns Hopkins University · P50 · FY2022 · CA
Rare Disease Network for Myasthenia Gravis
$1,588,974Henry J Kaminski · George Washington University · U54 · FY2022 · NS
Understanding and Improving Therapies for the Muscular Dystrophies
$1,588,673Hugh Lee Sweeney · University Of Florida · P50 · FY2021 · AR
Marinobufagenin as a therapeutic target
$1,588,518Edward Lakatta · National Institute On Aging · ZIA · FY2020 · AG
HIV Persistence During Suppressive Antiretroviral Therapy
$1,588,506Frank Maldarelli · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Parkinson's Disease Gene Therapy Study Group
$1,588,339University Of Rochester · U54 · FY2005 · NS
Development and Preclinical Applications of Pancreatic Adenocarcinoma Models
$1,588,248Shyam Sharan · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Mechanisms Of Action Of Psychoactive Drugs
$1,588,148De-Maw Chuang · National Institute Of Mental Health · ZIA · FY2014 · MH
Development of Recombinant Toxins to Treat Hematologic Malignancies
$1,588,137Robert Kreitman · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Development of PU.1 Inhibitory Modulators as Novel Therapeutics for Alzheimer's Disease
$1,587,671Li-Huei Tsai · Massachusetts Institute Of Technology · U01 · FY2022 · AG
Expression Genetics in Drug Therapy
$1,587,669Wolfgang Sadee · Ohio State University · U01 · FY2014 · GM
Prostate Cancer Bone Metastasis Biology and Targeting
$1,587,650Michael R Freeman · Cedars-Sinai Medical Center · P01 · FY2019 · CA